Nirsevimab Library
This is a collection of current resources related to Nirsevimab.
The Efficacy and Safety of Nirsevimab for the Prevention of RSV Infection Among Infants: A Systematic Review and Meta-Analysis
This article describes a study on nirsevimab, a new drug to prevent RSV infections in infants. RSV is a virus that can cause serious lung …
Ask aRCie
The Rapidly Changing Landscape of Respiratory Syncytial Virus Prophylaxis
2023
· University of Alberta,
· McGill University
The article describes the changing ways to prevent respiratory syncytial virus (RSV) in Canada. New methods include a monoclonal antibody called nirsevimab and vaccines for …
Effect of Palivizumab Prophylaxis on Respiratory Syncytial Virus Infection in Very Preterm Infants in the First Year of Life in The Netherlands
2023
· National Institute for Public Health and the Environment,
· University Medical Center Utrecht,
· Wilhelmina Children's Hospital
This article describes a study about using palivizumab to prevent RSV infections. It focuses on very preterm infants during their first year. The research took …
Formulary Drug Reviews: Nirsevimab
2024
· Washington State University
This article discusses the Formulary Drug Reviews on nirsevimab, a monoclonal antibody for preventing respiratory syncytial virus (RSV) in newborns and infants. It covers the …
Safety and Efficacy of Nirsevimab in a Universal Prevention Program of Respiratory Syncytial Virus Bronchiolitis in Newborns and Infants in the First Year of Life in the Valle d'Aosta Region, Italy, in the 2023-2024 Epidemic Season
This article describes a study on the safety and effectiveness of nirsevimab, a monoclonal antibody, in preventing RSV bronchiolitis in newborns and infants during the …
Impact of Nirsevimab Immunization on Pediatric Hospitalization Rates: A Systematic Review and Meta-Analysis (2024)
2024
· Servizio di Prevenzione e Sicurezza Negli Ambienti di Lavoro (SPSAL),
· University of Palermo,
· APSS Trento,
· University of Parma,
· Turin Local Health Authority
This article reviews the effects of nirsevimab immunization on reducing hospital visits for children. It describes how researchers looked at different studies to see if …
Game Over for RSV?
2023
· Yale University
This letter comments on a study by D. Wilkins and colleagues and concludes that passive immunization with nirsevimab protects infants from severe respiratory syncytial virus …
Evaluation of Antibody-Based Preventive Alternatives for Respiratory Syncytial Virus: A Novel Multi-Criteria Decision Analysis Framework and Assessment of Nirsevimab in Spain
2024
· University Carlos III,
· BioMad,
· Fisabio-Public Health,
· Catholic University of Valencia,
· Instituto de Salud Carlos III,
· Weber Foundation
This study evaluates nirsevimab, an antibody-based preventive measure for respiratory syncytial virus (RSV) in Spain. Using a multi-criteria decision analysis framework, experts found that nirsevimab …
Nirsevimab Immunization to Prevent Respiratory Syncytial Virus-Associated Lower Respiratory Tract Infections in Infants and Children up to 24 Months of Age
This article discusses nirsevimab, its side effects, and its implications for the nursing field. Respiratory syncytial virus (RSV) is a common virus infecting infants, causing …
Nirsevimab: A Review
This review article focuses on nirsevimab, a new monoclonal antibody approved by the FDA in July 2023 to prevent RSV disease in infants and young …